» Authors » Keizo Kasono

Keizo Kasono

Explore the profile of Keizo Kasono including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 141
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Takenouchi Y, Seki Y, Shiba S, Ohtake K, Nobe K, Kasono K
BMC Endocr Disord . 2022 Apr; 22(1):103. PMID: 35436932
Background: Chronic hyperglycemia in diabetes causes atherosclerosis and progresses to diabetic macroangiopathy, and can lead to coronary heart disease, myocardial infarction and cerebrovascular disease. Palmitoleic acid (POA) is a product...
2.
Sonoda K, Kono Y, Kitamori K, Ohtake K, Shiba S, Kasono K, et al.
Int J Mol Sci . 2022 Mar; 23(6). PMID: 35328352
Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that leads to liver cirrhosis and hepatocellular carcinoma. Endothelial dysfunction caused by hepatic lipotoxicity is an underlying NASH pathology observed in the...
3.
Oono K, Ohtake K, Watanabe C, Shiba S, Sekiya T, Kasono K
Lipids Health Dis . 2020 Feb; 19(1):15. PMID: 32005121
Background: n-3 polyunsaturated fatty acids (n-3 PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are thought to exert protective effects in cardiovascular diseases. In addition, n-3 PUFAs have demonstrated...
4.
Ohno Y, Seki T, Kojima Y, Miki R, Egawa Y, Hosoya O, et al.
J Pharm Health Care Sci . 2019 Nov; 5:22. PMID: 31687164
Background: Multiple daily subcutaneous injections (MDSIs) are mainly used for formulating an insulin therapy for diabetic patients; however, they also cause insulin-derived amyloidosis (IDA) and lead to poor glycemic control....
5.
Takenouchi Y, Tsuboi K, Ohsuka K, Nobe K, Ohtake K, Okamoto Y, et al.
Biol Pharm Bull . 2019 Sep; 42(9):1456-1463. PMID: 31474707
α-Lipoic acid (ALA) is used as a dietary supplement and known as an anti-oxidant. The present study aimed to examine whether ALA improves endothelial dysfunction in high-fat diet-fed obese mice....
6.
Takenouchi Y, Ohtake K, Nobe K, Kasono K
Lipids Health Dis . 2018 May; 17(1):118. PMID: 29788974
Background: Eicosapentaenoic acid (EPA) is thought to have many beneficial effects, such as anti-atherosclerogenic and anti-inflammatory properties. However, few studies have reported its effects of endothelial dysfunction in diabetes and...
7.
Nobe K, Takenouchi Y, Kasono K, Hashimoto T, Honda K
J Pharmacol Exp Ther . 2014 Aug; 351(1):77-86. PMID: 25085043
Contractile responses in small intrarenal arteries are associated with diabetic nephropathy. However, the mechanisms that induce and maintain altered small vessel contraction are not clearly understood. To further understand intrarenal...
8.
Wakutsu M, Tsunoda N, Mochi Y, Numajiri M, Shiba S, Muraki E, et al.
Biosci Biotechnol Biochem . 2012 Jun; 76(5):1011-4. PMID: 22738976
The effect on weight reduction of fish oil combined with food restriction in comparison with that of beef tallow was investigated in high-fat diet-induced obese KKAy mice. Although the reduction...
9.
Muraki E, Chiba H, Taketani K, Hoshino S, Tsuge N, Tsunoda N, et al.
Lipids Health Dis . 2012 May; 11:58. PMID: 22642742
Background: Various therapeutic effects of fenugreek (Trigonella foenum-graecum L.) on metabolic disorders have been reported. However, the bitterness of fenugreek makes it hard for humans to eat sufficient doses of...
10.
Muraki E, Hayashi Y, Chiba H, Tsunoda N, Kasono K
Lipids Health Dis . 2011 Dec; 10:240. PMID: 22188728
Background: We previously reported that fenugreek (Trigonella foenum-graecum L.) improved diet-induced metabolic disorders in rats. The purpose of the present study was to examine the dose-dependent effects, safety and tolerability...